Santen Pharmaceutical Co., Ltd. (SNPHY) reported a profit for its full year that Increased, from last year
The company's bottom line totaled JPY37.369 billion, or JPY113.80 per share. This compares with JPY36.256 billion, or JPY103.68 per share, last year.
The company's revenue for the period fell 2.8% to JPY291.624 billion from JPY300.004 billion last year.
Santen Pharmaceutical Co., Ltd. earnings at a glance (GAAP) :
-Earnings: JPY37.369 Bln. vs. JPY36.256 Bln. last year.-EPS: JPY113.80 vs. JPY103.68 last year.-Revenue: JPY291.624 Bln vs. JPY300.004 Bln last year.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.